NMPA Approval - Global Market Updates

AstraZeneca Fasenra approved in China for treating severe eosinophilic asthma, featuring an image of lungs and the medication.

Health

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

John - August 20, 2024 0

AstraZeneca's Fasenra (benralizumab) has been approved by China's National Medical Products Association (NMPA) for the treatment of severe eosinophilic asthma in patients aged 12...

Betul Mandi Bhav Today: Detailed Overview of Major Commodities

Sumeet Kumar - August 21, 2024

Wipro Expands Cloud Transformation Project with John Lewis Partnership

John - August 23, 2024

HCLTech Wins Top Spots in AWS GenAI Hackathons

John - August 9, 2024

Dr. Mansukh Mandaviya Hails Youth Volunteers as Torchbearers of Change on Pre-Independence Day Event

John - August 14, 2024

Tag: NMPA Approval

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

EDITOR PICKS

Betul Mandi Bhav Today: Detailed Overview of Major Commodities

Wipro Expands Cloud Transformation Project with John Lewis Partnership

HCLTech Wins Top Spots in AWS GenAI Hackathons

Dr. Mansukh Mandaviya Hails Youth Volunteers as Torchbearers of Change on Pre-Independence Day Event

EVEN MORE NEWS

Samsung Food+ Upgrades AI-Powered Features for Smarter, Healthier Cooking at IFA...

NVIDIA Launches AI-Driven NIM Agent Blueprint to Revolutionize Drug Discovery

Samsung Partners With Qualcomm to Enhance In-Vehicle Infotainment Systems

POPULAR CATEGORY